Caseware UK (AP4) 2022.0.179 2022.0.179 2022-11-302022-11-30Environmental consulting activities2021-11-17false2falsetrueThe members have not required the company to obtain an audit in accordance with section 476 of the Companies Act 2006. 13748823 2021-11-16 13748823 2021-11-17 2022-11-30 13748823 2020-12-01 2021-11-16 13748823 2022-11-30 13748823 c:Director2 2021-11-17 2022-11-30 13748823 d:CurrentFinancialInstruments 2022-11-30 13748823 d:CurrentFinancialInstruments d:WithinOneYear 2022-11-30 13748823 d:ShareCapital 2022-11-30 13748823 d:RetainedEarningsAccumulatedLosses 2022-11-30 13748823 c:OrdinaryShareClass1 2021-11-17 2022-11-30 13748823 c:OrdinaryShareClass1 2022-11-30 13748823 c:FRS102 2021-11-17 2022-11-30 13748823 c:AuditExempt-NoAccountantsReport 2021-11-17 2022-11-30 13748823 c:FullAccounts 2021-11-17 2022-11-30 13748823 c:PrivateLimitedCompanyLtd 2021-11-17 2022-11-30 iso4217:GBP xbrli:shares xbrli:pure

Registered number: 13748823










WALSOKEN LIMITED








UNAUDITED

FINANCIAL STATEMENTS

INFORMATION FOR FILING WITH THE REGISTRAR

FOR THE PERIOD ENDED 30 NOVEMBER 2022

 
WALSOKEN LIMITED
REGISTERED NUMBER: 13748823

STATEMENT OF FINANCIAL POSITION
AS AT 30 NOVEMBER 2022

2022
Note
£

  

Current assets
  

Stocks
 4 
95,612

Debtors: amounts falling due within one year
 5 
3,300

Cash at bank and in hand
  
2,238

  
101,150

Creditors: amounts falling due within one year
 6 
(104,280)

Net current liabilities
  
 
 
(3,130)

  

Net liabilities
  
(3,130)


Capital and reserves
  

Called up share capital 
  
1

Profit and loss account
  
(3,131)

  
(3,130)


The directors consider that the Company is entitled to exemption from audit under section 477 of the Companies Act 2006 and members have not required the Company to obtain an audit for the period in question in accordance with section 476 of the Companies Act 2006.

The directors acknowledge their responsibilities for complying with the requirements of the Companies Act 2006 with respect to accounting records and the preparation of financial statements.

The financial statements have been prepared in accordance with the provisions applicable to companies subject to the small companies regime and in accordance with the provisions of FRS 102 Section 1A - small entities.

The financial statements have been delivered in accordance with the provisions applicable to companies subject to the small companies regime.

The Company has opted not to file the statement of comprehensive income in accordance with provisions applicable to companies subject to the small companies' regime.

The financial statements were approved and authorised for issue by the board and were signed on its behalf on 29 November 2023.




S Mukherji
Director

The notes on pages 2 to 5 form part of these financial statements.

Page 1

 
WALSOKEN LIMITED
 
 
 
NOTES TO THE FINANCIAL STATEMENTS
FOR THE PERIOD ENDED 30 NOVEMBER 2022

1.


General information

Walsoken Limited is a private company limited by shares, incorporated England and Wales within the United Kingdom. The address of the registered office is Crown House, 108 Aldersgate Street, London, United Kingdon, EC1A 4JQ.
The company's functional and presentational currency is £ and the financial statements have been rounded to the nearest £.
These financial statements are prepared for an extended accounting period covering 17th November 2021 to 30 November 2022.

2.Accounting policies

 
2.1

Basis of preparation of financial statements

The financial statements have been prepared under the historical cost convention unless otherwise specified within these accounting policies and in accordance with Section 1A of Financial Reporting Standard 102, the Financial Reporting Standard applicable in the UK and the Republic of Ireland and the Companies Act 2006.

The following principal accounting policies have been applied:

 
2.2

Going concern

The company is reliant upon the shareholder for financial support who have confirmed their
continued support for the company.
The directors as a result of the shareholder's support, have prepared the accounts on a going concern basis.

  
2.3

Stocks

Stocks are stated at the lower of cost and net realisable value.
At each reporting date, stocks are assessed for impairment. If stock is impaired, the carrying amount is reduced to its selling price less costs to sell. The impairment loss is recognised immediately in profit or loss

 
2.4

Debtors

Short-term debtors are measured at transaction price, less any impairment. Loans receivable are measured initially at fair value, net of transaction costs, and are measured subsequently at amortised cost using the effective interest method, less any impairment.

 
2.5

Cash and cash equivalents

Cash is represented by cash in hand and deposits with financial institutions repayable without penalty on notice of not more than 24 hours. Cash equivalents are highly liquid investments that mature in no more than three months from the date of acquisition and that are readily convertible to known amounts of cash with insignificant risk of change in value.

Page 2

 
WALSOKEN LIMITED
 
 
 
NOTES TO THE FINANCIAL STATEMENTS
FOR THE PERIOD ENDED 30 NOVEMBER 2022

2.Accounting policies (continued)

 
2.6

Creditors

Short-term creditors are measured at the transaction price. Other financial liabilities, including bank loans, are measured initially at fair value, net of transaction costs, and are measured subsequently at amortised cost using the effective interest method.

 
2.7

Financial instruments

The Company only enters into basic financial instrument transactions that result in the recognition of financial assets and liabilities like trade and other debtors and creditors, loans from banks and other third parties, loans to related parties and investments in ordinary shares.

Debt instruments (other than those wholly repayable or receivable within one year), including loans and other accounts receivable and payable, are initially measured at present value of the future cash flows and subsequently at amortised cost using the effective interest method. Debt instruments that are payable or receivable within one year, typically trade debtors and creditors, are measured, initially and subsequently, at the undiscounted amount of the cash or other consideration expected to be paid or received. However, if the arrangements of a short-term instrument constitute a financing transaction, like the payment of a trade debt deferred beyond normal business terms or in case of an out-right short-term loan that is not at market rate, the financial asset or liability is measured, initially at the present value of future cash flows discounted at a market rate of interest for a similar debt instrument and subsequently at amortised cost, unless it qualifies as a loan from a director in the case of a small company, or a public benefit entity concessionary loan.

Investments in non-derivative instruments that are equity to the issuer are measured:
at fair value with changes recognised in the Statement of comprehensive income if the shares are publicly traded or their fair value can otherwise be measured reliably;
at cost less impairment for all other investments.

Financial assets that are measured at cost and amortised cost are assessed at the end of each reporting period for objective evidence of impairment. If objective evidence of impairment is found, an impairment loss is recognised in the Statement of comprehensive income.

For financial assets measured at amortised cost, the impairment loss is measured as the difference between an asset's carrying amount and the present value of estimated cash flows discounted at the asset's original effective interest rate. If a financial asset has a variable interest rate, the discount rate for measuring any impairment loss is the current effective interest rate determined under the contract.

For financial assets measured at cost less impairment, the impairment loss is measured as the difference between an asset's carrying amount and best estimate of the recoverable amount, which is an approximation of the amount that the Company would receive for the asset if it were to be sold at the reporting date.

Financial assets and liabilities are offset and the net amount reported in the Statement of financial position when there is an enforceable right to set off the recognised amounts and there is an intention to settle on a net basis or to realise the asset and settle the liability simultaneously.

Page 3

 
WALSOKEN LIMITED
 
 
 
NOTES TO THE FINANCIAL STATEMENTS
FOR THE PERIOD ENDED 30 NOVEMBER 2022

3.


Employees

The average monthly number of employees, including directors, during the period was 2.


4.


Stocks

2022
£

Project costs
95,612

95,612



5.


Debtors

2022
£


Other debtors
3,300

3,300



6.


Creditors: Amounts falling due within one year

2022
£

Other creditors
102,280

Accruals and deferred income
2,000

104,280



7.


Share capital

2022
£
Allotted, called up and fully paid


1 Ordinary share of £1.00
1




Page 4

 
WALSOKEN LIMITED
 
 
 
NOTES TO THE FINANCIAL STATEMENTS
FOR THE PERIOD ENDED 30 NOVEMBER 2022

8.


Related party transactions

Included in other creditors is £102,280 owed to Bia Power Limited (BVI), the ultimate controlling party.


9.


Controlling party

The ultimate controlling party is Bia Power Limited (BVI), a company registered in the British Virgin Islands.

 
Page 5